BCIS ACI 2020: Treating Shock in 2020
Published: 07 March 2020
This video series filmed at the BCIS ACI 2020 meeting features an expert panel who examine the issues around treating shock and PPCI, they discuss the treatment options and the future and consider if mechanical circulatory support can be used as a way forward.
- To consider the prevalence and burden of shock in contemporary practice
- To review the literature and data around treatment for shock patients
- To discuss best practice treatment strategy for shock patients
- To debate whether dedicated centres could improve outcomes
- To discuss upcoming clinical data that may improve decision making.
More from this programme
Prevalence of Shock and Outcomes in PPCI
How Should We Treat Shock?
Is MCS the Way Forward?
What’s on the Horizon?
Consultant, Clinical Lead
Dr Bethan Freestone is a consultant and clinical lead at University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
Anthony H Gershlick
Anthony Gershlick, Consultant Cardiologist at Leicester’s Hospitals and Honorary Professor of Interventional Cardiology at the University of Leicester.
Farzin Fath-Ordoubadi is a consultant interventional cardiologist based at Manchester Heart Centre, Manchester Royal Infirmary, Manchester, UK.
Keith G Oldroyd
Clinical Director of Cardiology
Professor Keith G Oldroyd MBChB; MD(Hons); FRCP(Glasg); FSCAI is a Consultant Interventional Cardiologist at the West of Scotland Regional Heart and Lung Centre in the Golden Jubilee National Hospital. He holds a personal chair within the Institute of Cardiovascular and Medical Sciences, University of Glasgow. He qualified in medicine from the University of Aberdeen in 1982.
In 2007 he became the first Clinical Director of Cardiology at the newly created West of Scotland Regional Heart and Lung Centre. From 2011-2014 he was also Director of R&D and currently he leads on CV research for NHS Scotland. His own research interests include the clinical and experimental assessment of novel drug eluting stents and the use of invasive physiological indices of stenosis severity to guide decision making in the cath lab. He has been a principal investigator in several international trials including FAME, FAME 2, PRAMI and LEADERS FREE, all of which have been published in the New…